Dividends Calendar Earnings Calendar
ZYNE

ZYNE | Zynerba Phamaceuticals Inc

Zynerba Phamaceuticals Inc
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Devon, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 181.92M
  • Prev closed: 4.73
  • Open: 4.95
  • High: 4.95
  • Low: 4.57
  • 52 week low: 2.55
  • 52 week high: 15.7
  • Dividends:No Dividends

Next ER: August 11, 2021 



Top Stories (ZYNE)

    Company Profile

    Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 15, 2021
    August 11, 2021- / -0.2229- / -
    May 12, 2021-0.2 / -0.25- / -
    March 15, 2021- / -0.3286- / -
    November 9, 2020-0.31 / -0.4329- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 31, 2021 4.360 4.140
    4.390
    4.140
    4.79M 6.08%
    Aug 30, 2021 4.110 4.158
    4.200
    4.050
    2.87M -0.96%
    Aug 27, 2021 4.150 4.080
    4.175
    4.040
    3.50M 1.72%
    Aug 26, 2021 4.080 4.140
    4.300
    4.060
    2.54M -2.86%
    Aug 25, 2021 4.200 4.170
    4.240
    4.075
    2.16M 0%
    Aug 24, 2021 4.200 4.030
    4.210
    3.990
    4.73M 5%
    Aug 23, 2021 4.000 3.820
    4.015
    3.800
    3.52M 6.95%
    Aug 20, 2021 3.740 3.680
    3.810
    3.664
    872.76K 0.54%
    Aug 19, 2021 3.720 3.850
    3.875
    3.700
    2.70M -3.88%
    Aug 18, 2021 3.870 3.990
    4.050
    3.840
    1.52M -1.53%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:28

    News

    News for (ZYNE)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Armando Anido
    • General Counsel :  Suzanne M. Hanlon
    • Chief Medical Officer :  Joseph M. Palumbo (Md, Fapa, Macpsych)

    Talk about Zynerba Phamaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 11, 2021 (Same day)

    ebay wen pam teo avt prgo zyne crbp wix ens nio fosl 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    s kmx lrcx bks etr sptn schw agn vips xray veev roku 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis